801 W. Baltimore Street | Baltimore, MD 21201


BioRemedies Launches Pre-clinical Study to Test CBD as Potential Therapeutic to Treat COVID-19

Press Release: June 3, 2020 University of Maryland and bioRemedies MD partner in CBD discovery Baltimore, MD (June 3, 2020) - A team led by the Ciaran Skerry, Ph.D., assistant professor of microbiology and immunology at the University of Maryland School of Medicine, partnered with bioRemedies MD to launch a pre-clinical study this week to examine whether cannabinoids (CBD) has anti-viral effects on cells infected with the COVID-19 virus in the laboratory. The researchers are utilizing a proprietary, custom-blended CBD formulated and produced by bioRemedies MD to understand the cannabinoid interactions surrounding respiratory diseases. COVID-19 (SARS-CoV-2) disease requires both the uptake of the virus into human cells and the promotion of host hyper-inflammatory responses. The inflammatory pathology closely resembles that seen in previous coronavirus outbreak strain SARS-CoV-1 where an...